Leyva-Flores R, Erviti-Erice J, Kageyama-Escobar M L, Arredondo A
Centro de Investigación en Sistemas de Salud (CISS), Instituto Nacional de Salud Pública (INSP), México.
Salud Publica Mex. 1998 Jan-Feb;40(1):24-31.
To analyze the medical prescription, drug access and drug expenditure by patients based on the National Health Survey in Mexico, 1994.
A descriptive analysis of drug access and expenditure was undertaken and predictive factors for medical prescription were identified by logistic regression for 3,324 patients.
78% of the patients received drug prescriptions. 92% of the Social Security patients and 35% of the Ministry of Health patients received drugs free of charge (p = 0.000). The region with the highest poverty index received the least amount of drugs free of charge. Regarding drug expenditure of patients who purchased drugs, median expenditure was 40.00 pesos (12.50 USD). Private health service patients spent significantly more than public health service patients.
Drug access and drug expenditure are linked to socioeconomic factors and to the institutions attended by patients. The Mexican health system faces, among others, the challenge of increasing the equity of access to medical drugs.
基于1994年墨西哥全国健康调查分析患者的医疗处方、药品获取情况及药品支出。
对药品获取和支出进行描述性分析，并通过逻辑回归确定3324例患者医疗处方的预测因素。
78%的患者接受了药物处方。92%的社会保障患者和35%的卫生部患者免费获得药品（p = 0.000）。贫困指数最高的地区免费获得的药品数量最少。对于购买药品的患者，药品支出中位数为40.00比索（12.50美元）。私立医疗服务患者的花费显著高于公立医疗服务患者。
药品获取和药品支出与社会经济因素以及患者就诊的机构有关。墨西哥卫生系统面临着诸多挑战，其中包括提高药品获取公平性的挑战。
